This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morchón, R.
Right arrow Articles by Simón, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morchón, R.
Right arrow Articles by Simón, F.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, October 2006, p. 1175-1176, Vol. 13, No. 10
1071-412X/06/$08.00+0     doi:10.1128/CVI.00197-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

High Levels of Serum Thromboxane B2 Are Generated during Human Pulmonary Dirofilariosis

R. Morchón,1 J. López-Belmonte,1 A. Rodríguez-Barbero,2 and F. Simón1*

Laboratorio de Parasitología, Facultad de Farmacia, Universidad de Salamanca, Avda. Campo Charro s/n 37007 Salamanca, Spain,1 Instituto Reina Sofia de Investigación Nefrológica, Departamento de Fisiología y Farmacología, Universidad de Salamanca, Campus Miguel de Unamuno 37007, Salamanca, Spain2

Received 31 May 2006/ Returned for modification 7 July 2006/ Accepted 26 July 2006


arrow
ABSTRACT
 
The canine parasite Dirofilaria immitis can infect humans. Patients with pulmonary dirofilariosis develop significantly higher thromboxane B2 levels than healthy individuals living in areas where dirofilariosis is endemic and in areas where dirofilariosis is not endemic. The possible role of Wolbachia bacteria in the appearance of this eicosanoid is discussed.


arrow
TEXT
 
Heartworm disease caused by Dirofilaria immitis in dogs and cats is distributed in temperate, subtropical, and tropical areas worldwide (7). The infection is transmitted by several mosquito species, most of which are able to feed on both animal reservoirs and humans. Thus, in areas of endemicity, people are at risk of infection. Human dirofilariosis is radiologically characterized by a solitary pulmonary calcified or noncalcified nodule (5, 15). These nodules appear when a migrating immature worm is trapped in a branch of the pulmonary artery and dies, causing coagulation necrosis with fibrosis and infiltration of inflammatory cells (8, 16). Wolbachia symbiont bacteria are a stable and abundant component of the bodies of many filarial species (2). In human D. immitis infections, high levels of immunoglobulin G (IgG) antibodies against the Wolbachia surface protein (WSP) have consistently been detected in patients with pulmonary dirofilariosis, while in healthy donors living in areas of endemicity, the levels of IgG anti-WSP are much lower (18). In addition, Wolbachia bacteria play an important role in the immunopathogenesis of both human filarial diseases (3, 19) and animal dirofilariosis (9). Eicosanoids are lipid mediators that regulate different physiological processes and modulate inflammatory and immunological responses in mammals (4). The effects of some of these eicosanoids antagonize the effects of others. Specifically, the thromboxanes (Txs) constrict blood vessels, suppress cyclic AMP, and promote platelet aggregation, while leukotrienes (LTs) are related to vascular permeability, chemotaxis, and polymorphonuclear leukocyte activation (17). Some of these lipid mediators have been observed in lymphatic filariae (10, 11, 13) and Onchocerca volvulus (4). Clinical studies have demonstrated high concentrations of TxB2 in the plasma of patients with septic and endotoxic shock (1) and in patients with chronic obstructive pulmonary disease (6).

The aim of this study was to investigate the levels of eicosanoids in the sera of patients with pulmonary dirofilariosis, a disease characterized by the inflammatory obstruction of pulmonary arteries and a disease in which the Wolbachia symbiont bacteria stimulate the immune systems of infected individuals.

Eighty human serum samples were divided into three groups. Group 1 (G1; n = 10) comprised serum samples from patients diagnosed with pulmonary dirofilariosis caused by D. immitis (these samples were kindly provided by Patrick Lammie from the Centers for Disease Control and Prevention, Atlanta, Ga.). These samples have high levels of specific IgG against WSP, as demonstrated previously (18). Group 2 (G2; n = 40) comprised serum samples from healthy individuals living in zones of endemicity in Spain and Italy with a positive serology (by enzyme-linked immunosorbent assay [ELISA]) for D. immitis antigens but without symptoms (healthy donors from areas of endemicity). Group 3 (G3; n = 30) comprised serum samples from healthy individuals living in an area of nonendemicity in Spain, where D. immitis infection in dogs and mosquitoes has not been recorded; these serum samples had a negative serology (by ELISA) for D. immitis and Wolbachia antigens (healthy controls). The levels of TxB2 and LTB4 in serum samples were analyzed by commercial ELISAs (R&D Systems). Briefly, serum samples were tested at 1:100 and 1:2 dilutions, respectively, for TxB2 and LTB4. The optical densities (ODs) at 405 nm were measured in an Easy Reader (Bio-Rad). The conversion of ODs to µg/ml was carried out by following the instructions of the manufacturers. The intra- and interassay precisions (coefficient of variation [CV]) ranged from 3.6 to 1.6% and from 7.7 to 6.2%, respectively, for TxB2. For LTB4, the CVs were 6.0 to 5.9% and 15.7 to 5.0%, respectively. The nonparametric Kruskal-Wallis test was used for multiple comparisons of the immunologic data. A significant difference was defined as a P value of <0.5, for a confidence level of 95%. For the paired samples, the Dunn test was used. In this case, a P value of <0.5 was considered significantly different.

The results are shown in Fig. 1. TxB2 levels were significantly higher in G1 than in G2 and G3 (P < 0.001). Significant differences in TxB2 levels were also observed between G2 and G3 (P < 0.001). Moderate LTB4 levels were observed only in healthy donors from areas of endemicity and not in individuals with pulmonary nodules or in healthy controls. Significant differences in LTB4 levels were detected between G2 and G3 and between G2 and G1 (P < 0.05) but not between G1 and G3.


Figure 1
View larger version (7K):
[in this window]
[in a new window]
  		FIG. 1. Levels of TxB2 and LTB4 in serum samples from individuals in G1, G2, and G3.

Humans are not an adequate host for D. immitis. In fact, most infections are caused by larvae inoculated by infected mosquitoes. The positive serology for D. immitis antigens observed in these individuals reflects an active or recent infection, but only some infected individuals develop pulmonary nodules (14). Prostaglandin E2 has been detected in the microfilariae of Wuchereria bancrofti and Brugia malayi (12) and in Onchocerca volvulus adult worms (4). Its presence is related to the survival of parasites in immunocompetent hosts, due to the capacity of this eicosanoid to stimulate the Th2-type anti-inflammatory response. This is consistent with the detection, in our work, of moderate levels of LTB4 only in healthy individuals living in areas of endemicity and who had active or recent infections caused by migrating immature worms. The high levels of TxB2 observed in patients with pulmonary dirofilariosis are consistent with the events occurring during the formation of the nodules. Inflammation and obstruction of the arteries described in human dirofilariosis could be mediated by thromboxanes through their vasoconstriction and platelet aggregation stimulus. Another interesting fact is that antibodies against WSP of Wolbachia were previously detected only in patients with pulmonary nodules (18), indicating that the bacteria are released from the dying worm into the artery lumen. Because TxB2 has been detected during septic shock (1), we suggest that the production of this eicosanoid could be associated, in human dirofilariosis, with the release of Wolbachia bacteria during the formation of the nodules. More studies on the participation of these and other eicosanoids are needed to obtain a correct understanding of the regulation of the events that are conducive to the formation of pulmonary nodules during human pulmonary dirofilariosis.


arrow
ACKNOWLEDGMENTS
 
This work was supported by grant SAF2003-05829 from the Ministerio de Ciencia y Tecnología of Spain.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Laboratorio de Parasitología, Facultad de Farmacia, Universidad de Salamanca, Avda. Campo Charro s/n, 37007, Salamanca, Spain. Phone: 34 923 294535. Fax: 34 923 294515. E-mail: fersimon{at}usal.es. Back


arrow
REFERENCES
 
    1
  1. Ball, H. A., J. A. Cook, W. C. Wise, and P. V. Halushka. 1986. Role of thromboxane, prostaglandins and leukotrienes in endotoxic. Intensive Care Med. 12:116-126.[Medline]
    2. 2
  2. Bandi, C., T. J. Anderson, C. Genchi, and M. L. Blaxter. 1998. Phylogeny of Wolbachia in filarial nematodes. Proc. Biol. Sci. 265:2407-2413.
    3. 3
  3. Brattig, N. W., U. Rathjens, M. Ernst, F. Geisinger, A. Renz, and F. W. Tischendorf. 2000. Lipopolysaccharide-like molecules derived from Wolbachia endobacteria of the filaria Onchocerca volvulus are candidate mediators in the sequence of inflammatory and antiinflammatory responses of human monocytes. Microbes Infect. 2:1147-1157.[CrossRef][Medline]
    4. 4
  4. Brattig, N. W., A. Schwohl, R. Rickert, and D. W. Buttner. 2006. The filarial parasite Onchocerca volvulus generates the lipid mediator prostaglandin E2. Microbes Infect. 8:873-879.[CrossRef][Medline]
    5. 5
  5. Cordero, M., A. Muro, F. Simon, J. I. Tapia, and E. Espinoza. 1992. Are transient pulmonary solitary nodules a common event in human dirofilariosis? Clin. Investig. 70:437-440.[Medline]
    6. 6
  6. Davi, G., S. Basili, M. Vieri, F. Cipollone, S. Santarone, C. Alessandri, P. Gazzaniga, C. Cordova, F. Violi, et al. 1997. Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 156:1794-1799.[Abstract/Free Full Text]
    7. 7
  7. Genchi, C., L. H. Kramer, and G. Prieto. 2001. Epidemiology of canine and feline dirofilariosis. A global view, p. 121-129. In F. Simón and C. Genchi (ed.), Heartworm infection in humans and animals. Ediciones Universidad de Salamanca, Salamanca, Spain.
    8. 8
  8. Hirano, H., T. Kizaki, T. Sashikata, and T. Matsumura. 2002. Pulmonary dirofilariosis—clinicopathological study. Kobe J. Med. Sci. 48:79-86.[Medline]
    9. 9
  9. Kramer, L. H., F. Tamarozzi, R. Morchón, J. López-Belmonte, C. Marcos-Atxutegi, J. R. Martín-Pacho, and F. Simón. 2005. Immune response to and tissue localization of the Wolbachia surface protein (WSP) in dogs with natural heartworm (Dirofilaria immitis) infection. Vet. Immunol. Immunopathol. 106:303-308.[CrossRef][Medline]
    10. 10
  10. Liu, L. X., and P. F. Weller. 1990. Arachidonic acid metabolism in filarial parasites. Exp. Parasitol. 71:496-501.[CrossRef][Medline]
    11. 11
  11. Liu, L. X., C. N. Serhan, and P. F. Weller. 1990. Intravascular filarial parasites elaborate cyclooxygenase-derived eicosanoids. J. Exp. Med. 172:993-996.[Abstract/Free Full Text]
    12. 12
  12. Liu, L. X., J. E. Buhlmann, and P. F. Weller. 1992. Release of prostaglandin E2 by microfilariae of Wuchereria bancrofti and Brugia malayi. Am. J. Trop. Med. Hyg. 46:520-523.[Abstract/Free Full Text]
    13. 13
  13. Longworth, D. L., D. W. Foster, A. M. Dvorak, and P. F. Weller. 1985. Incorporation of arachidonic acid by microfilariae of Brugia malayi. J. Infect. Dis. 152:1317-1323.[Medline]
    14. 14
  14. Muro, A., C. Genchi, M. Cordero, and F. Simón. 1999. Human dirofilariasis in the European Union. Parasitol. Today 15:386-389.[CrossRef][Medline]
    15. 15
  15. Navarrete, A. R. 1972. Pulmonary dirofilariasis. Chest 61:51-54.[Abstract/Free Full Text]
    16. 16
  16. Robinson, M. J., M. Viamonte, and M. Viamonte. 1974. Dirolilariosis: diagnostic consideration for pulmonary coin lesions. South. Med. J. 67:461.[Medline]
    17. 17
  17. Sala, A., and F. Gincarlo. 2001. Neutrophils, endothelial cells, and cysteinyl leukotrienes: a new approach to neutrophil-dependent inflammation? Biochem. Biophys. Res. Commun. 283:1003-1006.[CrossRef][Medline]
    18. 18
  18. Simon, F., G. Prieto, R. Morchon, C. Bazzocchi, C. Bandi, and C. Genchi. 2003. Immunoglobulin G antibodies against the endosymbionts of filarial nematodes (Wolbachia) in patients with pulmonary dirofilariasis. Clin. Diagn. Lab. Immunol. 10:180-181.
    19. 19
  19. Taylor, M. J., H. F. Cross, L. Ford, W. H. Makunde, G. B. K. S. Prasad, and K. Bilo. 2001. Wolbachia bacteria in filarial immunity and disease. Parasitol. Immunol. 23:401-409.[CrossRef][Medline]

Clinical and Vaccine Immunology, October 2006, p. 1175-1176, Vol. 13, No. 10
1071-412X/06/$08.00+0     doi:10.1128/CVI.00197-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morchón, R.
Right arrow Articles by Simón, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morchón, R.
Right arrow Articles by Simón, F.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»